Free Trial
NASDAQ:ALVR

AlloVir (ALVR) Stock Price, News & Analysis

AlloVir logo
$2.46 +0.06 (+2.50%)
As of 07/16/2025

About AlloVir Stock (NASDAQ:ALVR)

Key Stats

Today's Range
$2.40
$2.59
50-Day Range
$2.36
$4.30
52-Week Range
$7.96
$24.15
Volume
36,951 shs
Average Volume
15,383 shs
Market Capitalization
$12.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALVR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AlloVir and its competitors with MarketBeat's FREE daily newsletter.

ALVR Stock News Headlines

Kalaris Announces Closing of Merger with AlloVir
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Kalaris, AlloVir announce stockholder approval of merger
Allovir's Vikas Sinha sells shares worth $3,052
See More Headlines

ALVR Stock Analysis - Frequently Asked Questions

AlloVir's stock was trading at $9.66 at the start of the year. Since then, ALVR shares have decreased by 74.5% and is now trading at $2.46.

AlloVir, Inc. (NASDAQ:ALVR) issued its quarterly earnings data on Wednesday, August, 14th. The company reported ($1.15) earnings per share for the quarter, beating analysts' consensus estimates of ($2.30) by $1.15.

AlloVir shares reverse split on the morning of Thursday, January 16th 2025.The 1-23 reverse split was announced on Wednesday, January 15th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, January 15th 2025. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

AlloVir (ALVR) raised $252 million in an initial public offering (IPO) on Thursday, July 30th 2020. The company issued 14,800,000 shares at a price of $16.00-$18.00 per share. Morgan Stanley, J.P. Morgan, SVB Leerink and Piper Sandler served as the underwriters for the IPO.

Shares of ALVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that AlloVir investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), AU Optronics (AUOTY), DiamondRock Hospitality (DRH) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
8/14/2024
Today
7/17/2025
Next Earnings (Estimated)
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ALVR
CIK
1754068
Fax
N/A
Employees
110
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($20.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$190.42 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-71.03%
Return on Assets
-61.27%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
86.78
Quick Ratio
86.78

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$29.35 per share
Price / Book
0.08

Miscellaneous

Outstanding Shares
5,043,000
Free Float
3,425,000
Market Cap
$12.10 million
Optionable
Optionable
Beta
0.63
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:ALVR) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners